Wells Fargo & Company Revolution Medicines, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 58,172 shares of RVMD stock, worth $3.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,172
Previous 55,273 5.24%
Holding current value
$3.37 Million
Previous $2.15 Million 22.84%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$36.92 - $47.94 $107,031 - $138,978
2,899 Added 5.24%
58,172 $2.64 Million
Q2 2024

Aug 13, 2024
BUY
$30.14 - $40.68 $345,735 - $466,640
11,471 Added 26.19%
55,273 $2.15 Million
Q1 2024

May 10, 2024
BUY
$26.56 - $33.55 $101,884 - $128,697
3,836 Added 9.6%
43,802 $1.41 Million
Q4 2023

Feb 09, 2024
SELL
$18.35 - $34.12 $416,141 - $773,773
-22,678 Reduced 36.2%
39,966 $1.15 Million
Q3 2023

Nov 13, 2023
SELL
$25.17 - $35.05 $906,648 - $1.26 Million
-36,021 Reduced 36.51%
62,644 $1.73 Million
Q2 2023

Aug 15, 2023
BUY
$20.28 - $27.0 $552,609 - $735,723
27,249 Added 38.16%
98,665 $2.64 Million
Q1 2023

May 12, 2023
BUY
$20.76 - $30.09 $1.45 Million - $2.09 Million
69,610 Added 3854.37%
71,416 $1.55 Million
Q4 2022

Feb 13, 2023
SELL
$17.68 - $25.53 $32,106 - $46,362
-1,816 Reduced 50.14%
1,806 $43,000
Q3 2022

Nov 14, 2022
BUY
$17.46 - $26.0 $6,687 - $9,958
383 Added 11.82%
3,622 $71,000
Q2 2022

Aug 12, 2022
SELL
$14.54 - $27.17 $320,316 - $598,555
-22,030 Reduced 87.18%
3,239 $63,000
Q1 2022

May 16, 2022
SELL
$17.31 - $26.4 $362,661 - $553,106
-20,951 Reduced 45.33%
25,269 $646,000
Q4 2021

Feb 14, 2022
SELL
$24.35 - $33.7 $307,150 - $425,091
-12,614 Reduced 21.44%
46,220 $1.16 Million
Q3 2021

Nov 15, 2021
BUY
$23.95 - $33.41 $1 Million - $1.4 Million
41,915 Added 247.74%
58,834 $1.62 Million
Q2 2021

Aug 16, 2021
BUY
$29.0 - $47.44 $135,691 - $221,971
4,679 Added 38.23%
16,919 $536,000
Q1 2021

May 13, 2021
SELL
$37.21 - $54.43 $2.61 Million - $3.81 Million
-70,054 Reduced 85.13%
12,240 $561,000
Q4 2020

Feb 09, 2021
BUY
$30.19 - $45.49 $1.08 Million - $1.62 Million
35,617 Added 76.31%
82,294 $3.26 Million
Q3 2020

Nov 05, 2020
BUY
$22.61 - $34.8 $153,770 - $236,674
6,801 Added 17.06%
46,677 $1.62 Million
Q2 2020

Aug 13, 2020
BUY
$19.65 - $39.34 $617,854 - $1.24 Million
31,443 Added 372.86%
39,876 $1.26 Million
Q1 2020

May 14, 2020
BUY
$20.0 - $34.08 $168,660 - $287,396
8,433 New
8,433 $185,000

Others Institutions Holding RVMD

# of Institutions
267
Shares Held
161M
Call Options Held
260K
Put Options Held
620K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $5.07B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email